Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 676

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 676
---
 Kineta in connection with the Exchange are
reflected through the $1,225 adjustment to Kineta common stock recorded at par value, with $1,225 being recognized as the corresponding reduction to Kineta’s Additional paid-in capital in the pro forma
condensed combined balance sheet as of December 31, 2024, as a result of the adjustment to Kineta’s outstanding common stock before the Mergers. All of the outstanding equity of Kineta at the Effective Time, including the shares issued
pursuant to this Exchange Agreement, will be canceled and will cease to exist at the Effective Time in accordance with the Merger Agreement, only representing the right to receive the share of Merger Consideration (as stated in the Introduction).
Refer to adjustment Ewhere the cancellation of the Kineta equity as of the Effective time is reflected in the pro forma condensed combined balance sheet as of December 31, 2024.

HRepresents the estimated $1,305,724 of Kineta transaction costs (refer to adjustment F1) that are expected to be paid in cash
(or pre-Merger Kineta equity in lieu of cash) at the close of the Mergers but before the Closing Date by Kineta. This adjustment to the pro forma condensed combined balance sheet is assumed in order to satisfy
the maximum net working capital deficit amount permissible of $6,000,000 pursuant to the Merger Agreement; as amended in April 2025. While the calculation of the net working capital deficit pursuant to the terms of the Merger Agreement using the
historical financial information of Kineta as of December 31, 2024 would only be 5,872,781, which would be permissible under the amended Merger Agreement, the $1,432,943 of additional expenses expected to be incurred by Kineta subsequent to
December 31, 2024 that are directly attributable to the Mergers result in an excess of over the $6,000,000 permitted as the net working capital deficit. Since $1,600,993 of Kineta’s transaction costs were expected to be paid in cash at the
close of the Mergers, which would result in a direct increase to the net working capital deficit, in order to reflect a reduction in the expected deficit to the $6,000,000 permitted in the amended Merger Agreement, a pro forma adjustment was made to
reflect the $1,305,724 excess of these costs that will be expected to be paid via issuance